comparemela.com
Home
Live Updates
Vasomune Inc - Breaking News
Pages:
Latest Breaking News On - Vasomune inc - Page 1 : comparemela.com
AnGes : Tie2 receptor agonist (AV 001), co development product, received fast track designation from the U S FDA
May 29, 2024 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO Tie2 receptor agonist ,co-development.
United states
Brian jahns
Drug administration
Anges inc
Company name
Sunnybrook research institute at hospital
Vasomune therapeutics inc
Vasomune inc
National research council canada
Vasomune therapeutics
Fast track
Therapeutics inc
Track designation
Chief operating
United states department
Sunnybrook research institute
vimarsana © 2020. All Rights Reserved.